SMURF1 Regulates CTCF ‐ HOXA10 Axis and Promotes Tumor Progression in Nasopharyngeal Carcinoma
Cancer Science · 2026-05 · 117 (5) · 1346-1361
DOI: 10.1111/cas.70353 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 03.03.2026. Verfasst von Ying Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, CCCTC-Binding Factor, Nasopharyngeal Carcinoma, Homeobox A10 Proteins. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Doctoral Research Start-up Fund Project of the Affiliated Hospital of Guizhou Medical University, Guizhou Provincial Science and Technology Projects, Science and Technology Fund Project of Guizhou Provincial Health Commission in 2024.
Abstract (Originalsprache)
The aberrant upregulation of Homeobox A10 (HOXA10) has been implicated in the progression of nasopharyngeal carcinoma (NPC), but the mechanisms driving its upregulation are not fully elucidated. This study demonstrated that the E3 ubiquitin ligase SMAD ubiquitination regulatory factor 1 (SMURF1) promoted the ubiquitin‐mediated degradation of CCCTC‐binding factor (CTCF), thereby alleviating CTCF‐mediated transcriptional repression on HOXA10. Consequently, elevated HOXA10 expression contributed to tumor progression in NPC. We confirmed that HOXA10 was significantly upregulated in NPC and promoted malignant phenotypes of NPC cells. CTCF was identified as a direct transcriptional repressor of HOXA10 and was downregulated in NPC. Moreover, SMURF1 was found to be increased in NPC, where it directly bound to CTCF and regulated its protein stability. Specifically, SMURF1 promoted K48‐linked ubiquitination degradation of CTCF. In vitro functional assays revealed that SMURF1 knockdown inhibited NPC cell proliferation, migration, invasion, and epithelial‐mesenchymal transition. In vivo experiments further confirmed that SMURF1 knockdown suppressed NPC tumor growth and lung metastasis, accompanied by increased CTCF expression and decreased HOXA10 level in both tumor and lung tissues. Collectively, these findings revealed the SMURF1/CTCF/HOXA10 axis as a crucial mechanism in NPC pathogenesis, positioning SMURF1 as a promising therapeutic target for intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Otorhinolaryngology, The Maternal and Child Health Care Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou, China.
ORCID-Profile: Guodong Yu
Förderung
- Doctoral Research Start-up Fund Project of the Affiliated Hospital of Guizhou Medical University
- Guizhou Provincial Science and Technology Projects
- Science and Technology Fund Project of Guizhou Provincial Health Commission in 2024
Zitieren
APA
Jin, Y., Zhang, T., Wu, Z., Liang, Y., Jiang, Y., & Yu, G. (2026). SMURF1 Regulates CTCF ‐ HOXA10 Axis and Promotes Tumor Progression in Nasopharyngeal Carcinoma. Cancer Science, 117(5), 1346-1361. https://doi.org/10.1111/cas.70353
Vancouver
Jin Y, Zhang T, Wu Z, Liang Y, Jiang Y, Yu G. SMURF1 Regulates CTCF ‐ HOXA10 Axis and Promotes Tumor Progression in Nasopharyngeal Carcinoma. Cancer Science. 2026;117(5):1346-1361. doi:10.1111/cas.70353
BibTeX
@article{Jin2026,
author = {Jin, Ying and Zhang, Tian and Wu, Zhimin and Liang, Yuanshan and Jiang, Yiting and Yu, Guodong},
title = {SMURF1 Regulates CTCF ‐ HOXA10 Axis and Promotes Tumor Progression in Nasopharyngeal Carcinoma},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {5},
pages = {1346--1361},
doi = {10.1111/cas.70353}
}
EUVIMED